A detailed history of Bare Financial Services, Inc transactions in Genmab A/S stock. As of the latest transaction made, Bare Financial Services, Inc holds 22 shares of GMAB stock, worth $447. This represents 0.0% of its overall portfolio holdings.

Number of Shares
22
Holding current value
$447
% of portfolio
0.0%

Shares

1 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2025

May 12, 2025

BUY
$18.69 - $24.14 $411 - $531
22 New
22 $431,000

Others Institutions Holding GMAB

About GENMAB A/S


  • Ticker GMAB
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 658,292,992
  • Market Cap $13.4B
  • Description
  • Genmab A/S develops antibody therapeutics for the treatment of cancer and other diseases primarily in Denmark. The company markets DARZALEX, a human monoclonal antibody for the treatment of patients with multiple myeloma (MM); teprotumumab for the treatment of thyroid eye disease; ofatumurnab, a human monoclonal antibody to treat chronic lymphoc...
More about GMAB
Track This Portfolio

Track Bare Financial Services, Inc Portfolio

Follow Bare Financial Services, Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bare Financial Services, Inc, based on Form 13F filings with the SEC.

News

Stay updated on Bare Financial Services, Inc with notifications on news.